Emmaus Life Sciences, Inc. (EMMA)
0.0115
0.00 (0.00%)
USD |
OTCM |
May 18, 16:00
Emmaus Life Sciences Research and Development Expense (Quarterly) : 0.04M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 10.60M |
| Lexicon Pharmaceuticals, Inc. | 12.65M |
| Nutriband, Inc. | 0.188M |
| Liquidia Corp. | 12.27M |
| Q/C Technologies, Inc. | 0.5105M |